Intermittent Antimalaria Treatment With SP in African Children

• Status: Unknown status
• Trial end date: 2005-08-01
• Target enrollment: 0
• Participant gender: All

Summary

• intermittent preventive treatment with SP in children to evaluate efficacy and safety of this drug combination in children in northern Ghana

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Charite University, Berlin, Germany
• Collaborator: Deutscher Akademischer Austausch Dienst
• Treatments: Pyrimethamine

Criteria

Inclusion Criteria:

• informed consent by parents or guardian

• no concomitant serious disease

• age >2 months

Exclusion Criteria:

• serious allergy or hypersensitivity to sulfonamides or pyrimethamine

• no severe hepatic or renal dysfunction

• serious breach of study protocol